Absci (ABSI) Change in Account Payables (2020 - 2026)
Absci's (ABSI) quarterly Change in Account Payables came in at -$2.0 million in Q1 2026, up 6.46% year-on-year from -$1.9 million in Q1 2025, and down 5613.51% quarter-over-quarter from $37000.0 in Q4 2025.
Absci (ABSI) Change in Account Payables (2020 - 2026) Analysis & Trends
Absci has disclosed Change in Account Payables across 7 years of filings, most recently posting -$2.0 million for Q1 2026.
- Change in Account Payables for Q1 2026 came in at -$2.0 million, up 6.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (up 305.83% YoY), and the FY2025 annual result was $1.1 million, down 36.8% from the prior year.
- Change in Account Payables came in at -$2.0 million for Q1 2026 at Absci, down from $37000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $6.8 million in Q2 2025 to a low of -$3.6 million in Q3 2025.
- The 5-year median for Change in Account Payables is $22000.0 (2022), against an average of -$31411.8.
- Peak annual rise in Change in Account Payables reached 16607.32% in 2025, while the deepest fall reached 11940.0% in 2025.
- Absci's Change in Account Payables stood at $691000.0 in 2022, then sank by 158.76% to -$406000.0 in 2023, then jumped by 486.7% to $1.6 million in 2024, then tumbled by 97.64% to $37000.0 in 2025, then sank by 5613.51% to -$2.0 million in 2026.
- The last three Change in Account Payables figures came in at -$2.0 million (Q1 2026), $37000.0 (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | -2.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.04 Mn |
| Mar 31, 2026 | -2.04 Mn |
| Dec 31, 2025 | 37,000.00 |
| Dec 31, 2025 | 37,000.00 |
| Sep 30, 2025 | -3.61 Mn |
| Sep 30, 2025 | -3.61 Mn |
| Jun 30, 2025 | 6.85 Mn |
| Jun 30, 2025 | 6.85 Mn |
| Mar 31, 2025 | -2.18 Mn |
| Mar 31, 2025 | -2.18 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Sep 30, 2024 | -30,000.00 |
| Sep 30, 2024 | -30,000.00 |
| Jun 30, 2024 | 41,000.00 |
| Jun 30, 2024 | 41,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Dec 31, 2023 | -406,000.00 |
| Dec 31, 2023 | -406,000.00 |